Das Syndrom polyzystischer Ovarien und Metformin

Schnedl, W.

doi:10.1007/s41975-018-0034-4

J. Gynäkol. Endokrinol.

2018

DOI: 10.1007/s41975-018-0034-4

|View full text |Cite

Das Syndrom polyzystischer Ovarien und Metformin

W. Schnedl¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Use and preventive value of metformin in geriatric women with polycystic ovary syndrome

Aguilar

Herrera²,

Zurita³

2019

IJOAR

View full text Add to dashboard Cite

Research Article IJOAR (2019) 2:53 Use and preventive value of metformin in geriatric women with polycystic ovary syndrome Objective: To establish the effects of long-term use and preventive value of metformin in geriatric women with PCOS. Methods: A search of published review articles was carried out in sites such as NCBI, ScienceDirect, Elsevier, Springer, Wolters Kluwer, among others, using the key words: "polycystic ovary syndrome", "PCOS", "Polycystic ovary syndrome and metformin", " effects of metformin and PCOS "," insulin resistance and metformin "and" long-term sequelae of polycystic ovarian syndrome ". Results: We retrospectively analyzed data specific to the randomized clinical trial of Pedersen et al. 2017, to determine the impact that treatment had for twelve months with metformin in three specific variables: weight, total cholesterol and HDL. The study was conducted in 40 Caucasian women from 18 to 39 years of age, with a fixed dose of metformin (2 g / day for 12 months), who met the Rotterdam criteria for PCOS in their genetic variant MATE1 with SOP7 Conclusions: It was confirmed that the establishment of twelvemonth treatment with metformin in the randomized clinical trial of Pedersen et al. 2017 had a significant effect on the three specific variables: weight, total cholesterol and HDL.

show abstract

Use and preventive value of metformin in geriatric women with polycystic ovary syndrome

Aguilar

Herrera²,

Zurita³

2019

IJOAR

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Das Syndrom polyzystischer Ovarien und Metformin

Cited by 1 publication

References 29 publications

Use and preventive value of metformin in geriatric women with polycystic ovary syndrome

Use and preventive value of metformin in geriatric women with polycystic ovary syndrome

Contact Info

Product

Resources

About